Next »
Journal of Pain and Symptom Management
Volume 39, Issue 4
, Pages e1-e3
, April 2010
Management of Treatment-Related Intermittent Partial Small Bowel Obstruction: The Use of Octreotide
References
- . Assessment and management of mechanical bowel obstruction. In: Portenoy RK, Bruera E editor. Topics in palliative care. vol. 1:New York, NY: Oxford University Press; 1997;p. 13–16
- . Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients. J Pain Symptom Manage. 1992;7:496–498
- . A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy. Br J Cancer. 1995;71:97–101
- . Management of malignant bowel obstruction. Eur J Cancer. 2008;44:1105–1115
- . Vascular responsiveness in obstructed gut. Dis Colon Rectum. 1991;34:229–235
- . Importance of vasoactive intestinal peptide and somatostatin for fluid losses in small-bowel obstruction. Scand J Gastroenterol. 1995;30:464–469
- Does vasoactive intestinal polypeptide mediate the pathophysiology of bowel obstruction?. Am J Surg. 1989;157:109–115
- . Somatostatin. N Engl J Med. 1983;309:1495–1501
- Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer. J Pain Symptom Manage. 2005;30:563–569
- . Guidelines for management of small bowel obstruction. J Trauma. 2008;64:1651–1664
- Randomised clinical trial investigating the effects of combined administration of octreotide and methylglucamine diatrizoate in the older persons with adhesive small bowel obstruction. Dig Liver Dis. 2006;38:188–194
PII: S0885-3924(10)00084-9
doi: 10.1016/j.jpainsymman.2009.11.309
© 2010 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
Next »
Journal of Pain and Symptom Management
Volume 39, Issue 4
, Pages e1-e3
, April 2010
